Quantcast
Channel: Asbestos and Mesothelioma News » Mesothelioma
Viewing all articles
Browse latest Browse all 22

Verastem Inc. to Begin Developing Novel Mesothelioma Drug

$
0
0
Biopharmaceutical company Verastem, Inc. is gearing up for a phase II mesothelioma trial of a new drug, VS-6063. The drug has been in development for several years and shows promise in mesothelioma patients who lack the tumor-suppressor protein Merlin.

Viewing all articles
Browse latest Browse all 22

Trending Articles